Maribavir
CAS 176161-24-3 5 FDA-DMF suppliersSmall Molecule
Overview
Maribavir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL515408).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Maribavir expires 10 Oct 2043 and exclusivity 23 Nov 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2S,3S,4R,5S)-2-[5,6-dichloro-2-(propan-2-ylamino)benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol
- Canonical SMILES
- CC(C)NC1=NC2=CC(=C(C=C2N1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)Cl)Cl
- InChIKey
- KJFBVJALEQWJBS-XUXIUFHCSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.